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Abstract 
We describe in depth the structure of complexes formed between DNA and two classes of 
arginine-containing peptide amphiphiles, namely, the lipopeptide PRW-C16 (P= proline, R= 
arginine, W= tryptophan, C16= C16:0 alkyl chain) and the bolaamphiphile RFL4FR (R= 
arginine, F= phenylalanine, L= leucine). A combination of X-ray and neutron scattering 
provided unprecedented insights into the local structure of these complexes. Lipopeptide-based 
complexes self-assembled into layered structures with large-scale fractal features, hosting DNA 
in the interstices. Bola-amphiphile scaffolds were characterized by planar structures with DNA 
strands presumably sandwiched in-between peptide nanotapes. Importantly, complexation did 
not affect the structural integrity of DNA in either of the two complexes. The bolaamphiphile 
conjugates displayed high levels of molecular ordering in contrast to the liquid-crystalline 
features observed in lipopeptide assemblies. Peptide-DNA complexes were assessed for their 
potential as a means to deliver the reporter vector pEGFP-N1 into SW480 human colon 
carcinoma cells. Successfully transfected cells expressed Green Fluorescent Protein. The 
potentiating effect of PRW-C16 on the cellular uptake of ectopic DNA was found to be much 
greater than that observed with RFL4FR. In contrast to bolaamphiphile-based conjugate, the 
liquid-crystalline nature of the lipopeptide complex is likely to play a key role in DNA release 
and transfection efficiency since these weakly bound structures require lower energy 
expenditure during disassembly and load release.  
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Introduction 
Synthetic complexes for the transport and release of nucleic acids (NAs) are alternative 
delivery systems to engineered viral vectors with applications in the area of nucleic acid 
therapeutics including gene therapy.
1, 2
  The concept consists of creating a synthetic envelope to 
encapsulate polynucleotides, forming scaffolds that can be carefully designed to protect the 
cargo, promoting uptake across the membranes of targeted eukaryotic cells and facilitating 
endosomal escape following cellular uptake.
3
 Electrostatically, nucleotide sequences are highly-
anionic polyelectrolytes that carry one charge per phosphate group under physiological 
conditions.
4
 This characteristic has led to a considerable focus on various cationic species as 
obvious candidates for complex formation with DNA.
5
 Despite Coulomb attraction being 
evident in these systems however, there is general consensus that the entropy effects that appear 
upon counter-ion release from oppositely charged macromolecules are the underlying 
mechanism leading to the formation of thermodynamically stable complexes.
6, 7
 Lipids and 
polymers have been a preferred choice for designing non-viral carriers, which are often referred 
to as lipoplexes and polyplexes, respectively.
1
 Conjugates formed between NAs and 
amphiphilic moieties can self-assemble into a wide variety of liquid crystalline polymorphs,
5, 8
 
including multilamellar (“onion-like”) arrays,7  disc-shaped bicelles,9 hexagonal structures,10 
and cubic phases.
11
 Since cell transfection efficiency has been found to be dependent on a 
number of factors, including charge density and structural features,
12
 an accurate understanding 
of the spatial organization within such transfection complexes is of key importance in order to 
optimize intracellular cargo delivery.
5
  
Synthetic peptides are promising candidates as molecular carriers for biomedical 
applications thanks to their wide chemical diversity, ease of synthesis and intrinsic 
biocompatibility.
13, 14
 Recently, conjugates involving peptide self-assemblies have been 
formulated for molecular transport and their toxicity towards eukaryotic cells has been 
investigated.
15-17
 Previous studies conducted by our groups have also demonstrated the ability of 
arginine-rich sequences to self-assemble into nanoscopic polymorphs where cationic groups 
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appear spread across the interfaces of the nanostructures, thus being candidates to form 
complexes with anionic species.
16, 18, 19
 Here, we expand on these prior studies and scrutinize in 
detail the structure of conjugates obtained between DNA (both small linear fragments and 
plasmid vector) and short arginine-containing peptide amphiphiles (PAs). Arginine-rich 
sequences have been widely demonstrated to be highly efficient when it comes to promoting 
cell uptake and are extensively found in cell penetrating peptides (CPPs).
20, 21
 Several studies in 
which arginine-containing carriers have been compared to others containing cationic amino 
acids, including lysine which is also frequently used in CPPs,
20
 have systematically shown that 
arginine is more efficient at promoting membrane penetration.
21, 22, 23
 This has been attributed to 
the diffuse charge distribution and stronger H-bond donating capabilities observed in guanidium 
groups on arginine side-chains. In the current work, we also investigate the transfection 
potential of these PA/DNA complexes by monitoring the expression of plasmid-encoded 
enhanced green fluorescent protein (EGFP) in a human colon carcinoma cell line (SW480).   
In Figure 1, we show the chemical structures of arginine-based PAs used to produce 
conjugates with double-stranded DNA. Two types of PAs were used in our complexes: a 
surfactant-like peptide with a head group consisting of a PRW (P = proline, R = arginine, W = 
tryptophan) tripeptide, and a bolaamphiphile compound with the sequence RFL4FR (R = 
arginine, F = phenylalanine, L = leucine).
16
 Inclusion of the lipopeptide head group was based 
on the recognized effectiveness of arginine groups for enhancing cell membrane permeation
20, 24
 
and on the observation of the high frequency with which proline-rich sequences are seen in 
amphipathic cell-penetrating peptides
25
 (CPPs). In addition, tryptophan has been found to be a 
crucial residue for the uptake of CPPs and, thanks to its hydrophobic nature, it has also been 
assessed for interaction with the core of lipid plasma membranes.
26 
In the arginine-capped 
bolaamphiphile sequence, these moieties are thought to help membrane adhesion whereas the 
highly-hydrophobic FL4F central spacer assists the formation of stable nanosheets in water at 
very low concentrations.
16, 27
  We investigated the structure of PA/NA-complexes using a range 
of biophysical techniques including small-angle X-ray and neutron scattering (SAXS and 
SANS), fibre X-ray diffraction (XRD) and high-resolution cryogenic electron microscopy 
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(cryo-TEM) imaging. To formulate the complexes, we first used short NA fragments [~150 base 
pairs (bp)] obtained through sonication of calf thymus DNA. Once PA/DNA complexation was 
verified, we extended our investigations to include PA conjugation with the eukaryotic 
expression vector pEGFP-N1. This 4.7 kilobase pair (kbp) plasmid is usually in a super coiled 
state in solution and encodes a red-shifted variant of Green Fluorescent Protein (EGFP) which 
has been optimized for detection and expression in mammalian cells thus making it a suitable 
marker for cell transfection efficiency and DNA functionality following uptake by cells. Due to 
its larger size, the delivery of plasmid DNA can be very challenging.
28
 Conjugation with 
peptides however potentially induces DNA condensation, thereby reducing size and thus 
facilitating penetration across plasma and nuclear membrane barriers. Unlike other nucleotides, 
such as short interfering RNA (siRNA) which requires only cytoplasmic release, plasmid DNA 
requires intra-nuclear delivery as a pre-requisite for gene expression. We demonstrate here the 
interaction of these lipopeptide and bolaamphiphilic peptides with plasmid DNA and show their 
capacity to enhance the cellular uptake of their cargo whilst maintaining its functionality as 
evidenced by the expression of EGFP in target cells.  
 
Materials and Methods 
Peptide Amphiphiles: Both peptides were custom-synthesized by CS Bio (Merlo Park, CA, 
USA), with TFA as a counter ion. The lipopeptide PRW-C16 had its purity determined to be 
95.4% and a molar mass of Mw = 681.6 g (expected 681.98 g), as attested by HPLC and 
electrospray-mass spectroscopy. The bolaamphiphile RFL4FR had a purity of 97.5% and a 
molar mass of Mw = 1076.86 g (expected: 1076.36 g). In both cases the dry powder was kept 
refrigerated at -20 °C and samples were prepared by dissolving weighed amounts into ultrapure 
water. Prior to mixing with DNA, peptides were dissolved at 10 mg/mL in Trizma buffer (pH 
adjusted at 7.4) or Phosphate Buffered Saline (PBS) buffer (pH at 7.4). In the case of RFL4FR, 
samples were ultrasonicated for about 20 min at ~55 °C in order to reach complete dissolution.  
Nucleic Acids: Calf thymus DNA was obtained from Sigma-Aldrich (Saint Louis, MO, USA) 
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in the form of dried fibres. These were re-hydrated with ultrapure water and transferred into 
glass vials at a concentration of 10 mg/mL. They were then homogenised by vigorous shaking 
for 2 h and sonicated for about 30 h in an ultrasound bath until fragments of average size 150 bp 
were obtained as determined by electrophoresis, as previously reported.
29, 30
 The fragments used 
in further experimentation had sizes generally roughly corresponding to the DNA persistence 
length (i.e., ~ 50 nm). The vector pEGFP-N1 (Clontech Laboratories, Mountain View, CA, 
USA) was used for PA/plasmid interaction gel retardation assays [also known as Bandshift or 
Electrophoretic Mobility Shift Assays (EMSA)] and for transfection studies. This 4.7 kilobase 
pair plasmid expresses an enhanced green fluorescent protein (EGFP) and was purified from E. 
coli DH5 using a QIAGEN plasmid purification maxi kit (Valencia, CA, USA). The purity and 
concentrations of plasmid preparations were ascertained by agarose gel electrophoresis (1% 
agarose) and UV absorption using a NanoDrop instrument (Thermo Scientific, Wilmington, DE, 
USA), respectively.  
PA/DNA complexes: Peptides and DNA were dissolved in buffer (100 mM Trizma or PBS, 
pH 7.4) at typical final concentrations of ~5 mg/mL for peptides and ~3mg/mL for DNA. 
Concentrations were chosen so that arginine-to-phosphate molar ratios were equal to one. Thus, 
calculations were made considering two phosphate groups per nucleotide base pair (Mw = 660 
g), one arginine side-chain per molecule of lipopeptide PRW-C16 and two arginine residues per 
bolaamphiphilic sequence RFL4FR. Under these conditions, formulations made with plasmid 
formed a white precipitate upon mixing, whereas samples prepared with DNA fragments 
formed a turbid solution. In neutron scattering assays, the procedure was similar to that 
described above; however, samples were diluted using H2O/D2O mixtures (see details below).  
Cryo-TEM assays: Cryogenic transmission electron microscopy (cryo-TEM) imaging was 
performed as detailed elsewhere.
16
 Briefly, the instrument was a JEOL JEM-3200FSC operating 
at 300 kV. The microscope was used in bright-field mode with a slit width of 20 eV and images 
were recorded with a Gatan Ultrascan 4000 CCD camera. Droplets containing about 3 μL of 
PA/DNA suspensions were cast onto copper grids, blotted once for 1 s and then vitrified (in a 
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FEI Vitrobot device) in a 1:1 mixture of liquid ethane and propane at −180 °C. Grids with 
vitrified samples were maintained in liquid nitrogen before being transferred into the 
microscope.   
X-ray diffraction (XRD): XRD patterns were obtained from dried stalks. Pellets of PA/DNA 
complexes were suspended between the ends of wax-coated capillaries. This assembly was 
carefully placed within Petri dishes sealed with parafilm and left to dry for a period of days 
within the fridge at 4° C. To facilitate the drying process, silica gel beads were deposited within 
the Petri dishes. Typically, the formation of dried stalks was observed after 3-4 days of 
incubation. Stalks were vertically positioned onto a RAXIS IV++X-ray diffractometer (Rigaku) 
using a rotating anode generator as X-ray source. Data were registered using a Saturn 992 CCD 
camera at a sample-to-detector distance of 40 mm. Data reduction was performed using Fit2D 
software (ESRF) and unit cell optimization and simulations were carried out with the program 
CLEARER.
31
   
Synchrotron Small-Angle X-ray Scattering (SAXS) : Synchrotron SAXS from samples 
prepared with the lipopeptide PRW-C16 was performed on the beamline SWING at SOLEIL 
(Saint Aubin, France), whereas preparations made with the bolaamphiphile RFL4FR were 
examined on beamline I911-4 at MaxLab II (Lund, Sweden). On SWING-SOLEIL, the 
wavelength was set at  = 1.03 Å and sample-to-detector distance was 1,526.4 mm. SAXS 
patterns were recorded using a 2D Aviex 170170 detector. Measurements in solutions 
containing DNA fragments were performed using the bioSAXS setup with the automatic sample 
changer available on the beamline. About 50 L of each solution containing PA/DNA 
complexes were flowed through a 1 mm quartz-capillary. Automated washing steps were 
performed between every measurement and background assessments were made prior to and 
after sample registering. To avoid radiation damage, 50 frames (500 ms per frame) were 
grabbed during sample flow. The frames were compared and, if no damage was detected, they 
were averaged and the background was subtracted. For samples prepared with plasmid, 
plasmid/peptide pellets were transferred into individual 1 mm quartz capillaries and centrifuged 
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to the bottom. On beamline I911-4 at MaxLab, the procedure was quite similar. The X-ray 
wavelength was  = 0.91 Å and the sample-to-detector distance was 915 mm. Data was 
recorded by a Pilatus 1M detector and 4 frames, 30 s each, were recorded, compared and, if no 
radiation damage was observed, averaged. Radial averaging was performed with Fit2D and 
frame averaging and background subtraction was carried out using the SAXS Utilities program.  
Small-Angle Neutron Scattering (SANS): SANS experiments were carried out either on 
the SANS-1 instrument at the Heinz-Meier Leibnitz Zentrum (MLZ) reactor (Garching, 
Germany), or on the time-of-flight LOQ beamline, at the ISIS spallation source (Didicot, UK). 
On SANS-1 at -MLZ, where complexes formed between short DNA fragments and the peptide 
bolaamphiphile RFL4FR were investigated, the neutron beam had   = 5.5 Å ( = 6 %) and 
cross section  = 8 mm. Three geometries were used to cover a wide q-range: sample-to-
detector distance SDD = 19.99 m with collimation COL = 20 m, SDD = 7.99 m with COL = 8 
m and SDD = 1.2 m with COL = 4 m, leading to scattering vectors in the interval 0.05 nm
-1  q 
  6 nm-1. Detection was performed by an array of 128 3He position-sensitive tubes, with an area 
of 1000  1020 mm² and a resolution of 8 mm. Radial averaging and data reduction were 
performed using the package BerSANS. A cadmium shield was placed in front of the beam to 
assess electronic noise and measurements of empty beam and water transmission were 
performed in order to correct and normalize the data. On LOQ at ISIS, where conjugates 
between DNA fragments and the lipopeptide PRW-C16 were probed, sample-to-detector 
distance was kept at SDD = 4m and a “white” beam with  = 12 mm and wavelengths in the 
range 2.2 Å   10 Å allowed access to the q-range interval of 0.2 nm-1  q  2.5 nm-1. 
Detection was carried out by a 
3
He-CF4 area detector with an active surface of 640  640 mm². 
Data reduction was performed with the Mantid package. All samples were loaded into Hellma 
banjo cells with a path length l = 1 mm. Since nucleotides and peptides have very different 
scattering length densities (SLD) for neutron scattering, samples for SANS were formulated 
using the solvent matching approach.
32
 This technique consists in preparing solutions with 
different proportions of D2O in the solvent to separately match SLDs of different phases in the 
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complexes. At least four samples of PA/DNA fragments complex (peptide at 5 mg/mL) were 
dissolved in solutions with D2O/[D2O + H2O] molar ratios of 0% (fully hydrogenated solvent), 
39%, 66% and 100% (fully deuterated). Ratios of 39% and 66% were chosen to match the SLD 
of peptides and DNA, respectively.
33
 Fully hydrogenated or fully deuterated mixtures were used 
for providing highly positive and highly negative contrasts, respectively.
33
  
Gel retardation assays: Varying quantities of each peptide were added to 100 ng of plasmid 
in a final volume of 10 L. Peptide/plasmid mixtures were incubated for 30 min at 37 °C and 
then electrophoresed in 1% agarose with Tris-Acetate-EDTA (TAE) buffer. Gels were stained 
using SyBr-Safe (ThermoFisher Scientific) prior to band visualization using a UV 
transilluminator. The appearance of plasmid bands with reduced electrophoretic mobility was 
evidence of PA/DNA complexation.  
Cell culture, cytotoxicity assays and in vitro transfections: SW480 cells (DSMZ 
Braunschweig, Germany) were grown in Dulbecco’s Minimal Essential Medium (DMEM) 
supplemented with heat-inactivated 10% foetal bovine serum (FBS) and 1% penicillin-
streptomycin at 37 
°
C in a humidified 5% CO2 atmosphere. Cells were split and fed immediately 
prior to confluence every 2 to 3 days following removal with trypsin/EDTA (all cell culture 
products were from Gibco/Thermo Fischer Scientific, Waltham, MA, USA). Peptide 
cytotoxicity was evaluated using the fluorogenic indicator dyes Alamar blue [AlamarBlue® 
(AB) (Bio-Source, Invitrogen)] and CFDA-AM (5-carboxyfluorescein diacetate acetoxymethyl 
ester; Molecular Probes, Invitrogen), essentially as described elsewhere.
34
 A linear relationship 
between cell number/well and absorption was first established and based on this SW480 cells 
were seeded under test conditions at 25,000 cells/well of a black 96 well plate. In brief, after 48 
h of incubation with peptide, the medium was removed completely and 100 μL/well of the 
Alamar blue/CFDA-AM working solution was added. Fluorescence was measured 30 min later 
at 530 nm excitation/590 nm emission for AB and 485 nm/535 nm for CFDA-AM, respectively, 
using a multi-well scanning spectrophotometer. Average values of triplicates were calculated 
following background correction and cited as “viability (%)” following reference to vehicle-
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only treated controls. Cell uptake was also qualitatively assessed through fluorescence 
microscopy assays. SW480 cells were seeded as above in 96 well plates 24 h before 
transfection. On the day of transfection a quantity of each peptide (300 ng of PRW-C16 or 250 
ng of RFL4FR) was added to 100 ng of plasmid (pEGFP-N1), made up to a volume of 20 l 
using molecular grade water and incubated at 37
o
C for 30 min to allow peptide-DNA 
complexation. Cell culture medium was then removed and replaced with 100 l of fresh serum-
free medium containing peptide-DNA complex (80 l medium plus 20 l peptide-DNA 
complex) followed by incubation at 37°C for 1 h. Culture medium containing peptide-DNA 
complex was then removed and replaced with fresh complete medium. The transfection reagent 
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) was used as per manufacturer’s 
instructions. Forty-eight hours after transfection, cells were stained with Diamidino-2-
phenylindole (DAPI) and observed using an Olympus BX51 Fluorescent Microscope. Images 
were split into separate channels (DAPI and EGFP) and analysed using Image J software. Three 
images were scored for each condition (a total of at least 500 cells in each case). Transfection 
efficiencies were estimated by dividing the number of cells with EGFP fluorescence by the 
number of DAPI-stained nuclei and expressed as percentages. Each DAPI-stained nucleus was 
counted as one cell. The data presented was compiled from three independent experiments and 
are presented as means ± standard deviations (±SD). 
Results and Discussion 
Structural analysis of peptide complexation with short DNA fragments 
We first ascertained the structure of complexes formed between PAs and short DNA 
fragments. The goal of these preliminary studies was to probe the viability of complexation 
using model conjugates which are likely to be simpler than complexes prepared from high-
molecular-weight sequences.
29, 35
 The fragments were ~150 base pairs long, roughly 
corresponding to the persistence length of the biopolymer.
4
 In this case, DNA duplexes could be 
approximated by rigid rods with lengths of ~50 nm and diameters of ~ 2 nm. As will be 
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discussed below, the local structure of complexes using DNA fragments retains remarkable 
similarities with the local structures of complexes made from plasmid DNA. Another advantage 
of using such short fragments as a model is their relatively low cost in contrast to longer 
plasmid sequences. This is a critical issue, especially for preparing samples for neutron 
scattering which require much larger DNA quantities than those needed for transfection assays 
or structural analyses using X-rays or cryo-TEM.  
In Figures 2A and B, we show high-resolution SAXS either from single-phase 
formulations – i.e., samples containing only DNA or PAs – or from preparations with peptides 
and nucleic acids dissolved at a 1:1 arginine-to-phosphate ratio. Scattering profiles from single-
phase samples were smooth, without Bragg peaks and can be modelled in terms of analytical 
form factors
36
. Data collected from solutions containing only DNA fragments (bottom curves in 
Figure 2A and B) was fitted according to a cylinder-shell form factor
33, 36
 with fitting parameters 
of L = 51.9 nm for the length, R = 0.98 nm for the core radius and R = 0.40 nm for the shell 
thickness. These values are in close agreement with dimensions expected for 150 bp DNA rods 
plus Na
+
 counter ion solvation shells.
37
 The cylinder-shell form factor was also used for fitting 
data from samples prepared with the lipopeptide PRW-C16 dissolved in buffered solutions 
(middle curve in Figure 2A). The fitting parameters were as follows: L = 187.4 nm, R = 1.61 
nm and R = 1.33 nm, consistent with cylindrical micelles with cores built up from C16:0 alkyl 
chains
38
 and outer shells made up from a tripeptide functional group (3  0.34 = 1.02 nm) plus a 
counter ion layer.
39
  SAXS profiles from solutions containing the bolaamphiphile RFL4FR 
(middle curve in Figure 2B) were consistent with nanosheets as previously described.
16
  SAXS 
data from these formulations was fitted with a bilayer form factor,
40
 revealing an effective 
membrane thickness of t = 3.0 nm, in agreement with bolaamphiphile membranes built up from 
pairing of octameric strands with length 8  0.34 = 2.7 nm39 plus a counter ion solvation shell.  
SAXS curves from samples containing both DNA and peptides are much more intricate 
than data from single-phase solutions. We found that these curves are not appropriately 
described by linear combinations of their single components, a finding that has been interpreted 
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as evidence for complexes in solution.
33
  In this case, curves were dominated by Bragg peaks at 
intermediate q-range (black arrows in Figure 2) indicating the presence of highly-ordered 
structures at the nanoscale level and pointing out the appearance of new levels of organization 
in the assemblies. Analysis of scattering behaviour across the q-range examined revealed 
valuable information on the multi-hierarchical structure of the arrays. The low-q range of SAXS 
profiles from samples incorporating the lipopeptide PRW-C16 was characterized by a linear 
descent scaling with ~q
-3.6
 (upper curve in Figure 2A). This value for the Porod exponent reveals 
a typical feature of long-range clustering in biological macromolecules
41
 and suggested 
structures with sharp interfaces and a surface fractal dimension of Ds = 6 - 3.6 = 2.4.
41, 42
 An 
intense peak at q0 = 1.12 nm
-1
, followed by its second order at q1 = 2.25 nm
-1
, indicated a repeat 
distance of d = 2/q0 = 5.6 nm which can be ascribed to the separation between layers in a 
lamellar structure containing DNA in the interstices. Since the diameter of double-stranded 
DNA without a counter ion solvation shell was around 2 nm,
4
 lamellae formed upon 
complexation can be smaller than rod-like micelles formed by the lipopeptide. In this case, 
PRW-C16 likely self-assembled into interdigitated bilayers with a thickness estimated at ~ 3.6 
nm, similar to the organization observed for other C16 lipopeptides.
43
 We propose that the 
appearance of these interlocked structures is driven by condensation of PRW-C16 monomers 
mediated by DNA strands and that this induces the formation of lamellar aggregates with 
increased amphiphile concentration. This condensation step is then followed by inter-aggregate 
interactions which promote fusion of local lamellar domains and lead to long-range assemblies 
with fractal features.  The full width at half maximum (FWHM) of the first-order peak was 
measured through Lorentzian fits (not shown) at FWHM = 0.22 nm
-1
, implying a correlation 
length of = 2/FWHM = 28.5 nm, which corresponded to about d/5 correlated layers in 
the assemblies.    
The low-angle regions in the SAXS profiles from solutions prepared with the 
bolaamphiphile RFL4FR exhibited a ~q
-2
 behaviour, indicating planar structures in the 
complexes (upper curve in Figure 2B). The intermediate range was dominated by a strong 
reflection at q = 1.28 nm
-1
, corresponding to a periodicity of d = 4.9 nm, in close agreement with 
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the summation of one DNA duplex diameter plus the thickness of the octapeptide nanosheets (d 
= 2  0.98 + 3.0 = 4.96 nm). The correlation length was estimated at  = 9.1 nm, corresponding 
to only ~ 1.9 PA/DNA galleries (on average) and indicating a very low number of correlated 
sheets. This strong first-order reflection was followed by a shallow shoulder at q ~ 2.10 nm
-1
, 
which was ascribed to interaxial spacing of DNA strands within the plane of nanosheets with 
periodicity dDNA = 3.0 nm. This distance is enough to accommodate one double helix diameter 
plus a few hydration layers and it is quite similar to separations found elsewhere in 
multilamellar complexes prepared with cationic
7, 44
 and zwitterionic lipids.
29, 35
 Putting the 
findings above together, our SAXS data suggest these bolaamphiphile complexes were 
organized into flat peptide membranes with DNA strands sandwiched in between nanosheets, 
with a limited number of galleries of alternating peptides and nucleic acids. 
To get further insights into the structure of the complexes, we carried out small-angle 
neutron scattering (SANS) combined with the contrast-matching technique.
32, 33
 The advantage 
of using neutrons instead of X-rays is that, by changing the relative amount of deuterium in the 
solvent - i.e., the [D2O]/([H2O] + [D2O]) molar ratio -, it is possible to separately match the 
scattering length density of each phase within the complex and discriminate its scattering from 
the signal of the other phase.
32
 Our samples were prepared in solvents containing at least four 
D2O percentages for providing strong negative contrast (100% D2O), strong positive contrast 
(0% D2O) and matching contrast points of DNA (66% D2O) and peptides (39% D2O). SANS 
curves from these assays are shown in panels in Figures 2C and D. Looking at SANS data from 
complexes prepared with the lipopeptide PRW-C16 (Figure 2C), one observes that the curves 
carry different information depending on the solvent composition. At higher D2O amounts, 
when scattering is dominated by the peptide component,
45
  the curves are characterized by a 
linear descent at low-q and a Bragg peak at higher q. The Porod exponent in this case was 
determined at – 4 and the Bragg peak was found at q = 1.13 nm-1, in close agreement with the 
SAXS data presented above. Due to the lower resolution of SANS, the second order of this 
reflection is not detected. Therefore, the presence of surface fractal aggregates and local layered 
structures with repeat distances of d = 5.5 nm was also confirmed by neutron scattering. Since 
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the general features of the curves remained essentially the same at 66% D2O, when scattering 
from DNA is minimized and signals from the peptide phase is highlighted, we can conclude that 
the layered structures arose from lipopeptide assembly. As the amount of deuterium in the 
solvent decreases, the shape of the SANS profiles changes dramatically. At 39% D2O, the 
contrast point of peptides was matched and scattering was dominated by the DNA phase. In this 
case, the characteristic Porod-like behaviour at low-q region vanished indicating that stiff DNA 
fragments were not capable of forming a clustered array on their own. In contrast, a diffuse band 
is still noticeable in the vicinities of q = 1.13 nm
-1
, suggesting that the periodicity of d = 5.5 nm 
was also associated with nucleic acid fragment layers which were likely to be in-between 
interdigitated bilayers of the template peptide scaffold. In D2O-free mixtures, the clustering 
feature at small angles was retrieved since the peptide component now contributes to the overall 
scattering. The Bragg peak at intermediate range in this case was hidden below incoherent 
scattering from H nuclei in the solvent.
32
   
SANS data from complexes prepared with the bolaamphiphile RFL4FR are shown in 
Figure 2D. Again, solutions containing higher D2O amounts exhibited scattering profiles similar 
to those observed in SAXS, demonstrating that the overall structure of the complex is mainly 
driven by the peptide phase. The low-q range is characterized by a scaling law with ~ q
-2.1
, 
consistent with planar assemblies in solution; a diffuse peak found at q ~ 1.3 nm
-1
 corroborated 
repeat distances of d = 4.8 nm, associated with the juxtaposition of one duplex DNA and one 
cross-section RFL4FR nanosheet. A small shoulder at q ~ 2.1 nm
-1
, ascribed to in-plane DNA-
DNA spacing, was noticeable only at 100% D2O, when incoherent scattering was kept to a 
minimum and improved signal-to-noise ratio allowed for its observation. At 66% D2O, DNA 
scattering was minimized and the presence of a peak at q ~ 1.3 nm
-1
 confirmed that this 
periodicity arose from self-assembly of the peptide phase.  At 39% D2O, with peptide signal 
reduced, SANS profiles resembled those found in DNA rods (see SI file, Figure S1). The peak 
at q ~ 1.3 nm
-1
 appeared diffuse and suggested that DNA fragments form a periodic array within 
the layered structure of the peptide phase. At 0% D2O, the low q scaling behaviour was 
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recovered and the correlation peak at the intermediate region disappeared due to incoherent 
scattering of water. 
Based on the scattering data presented above, we propose models to describe spatial 
ordering in the complexes formed either by PRW-C16 or by RFL4FR peptides. Schematic 
drawings of these models are shown in Figure 3, where both large-scale and local structures are 
depicted. Also, tentative self-assembly pathways leading to the formation of PA/DNA 
complexes are shown with intermediate condensation steps. The lipopeptide-based complex, 
shown in Figure 3A-E, is represented by irregular aggregates with surface fractal features and 
an inner structure containing local domains with a lamellar organization. The process likely 
starts with the condensation of lipopeptide micelles mediated by highly-anionic DNA strands 
(Figure 3A), which leads to the formation of aggregates with increased amphiphile 
concentration followed by fusion into short-range lamellar domains (Figure 3B). Within these 
domains, interdigitated bilayers appear intercalated with DNA fragments hosted in hydrophilic 
channels with a layer periodicity of ~ 5.6 nm (Figure 3C). These local structures are composed 
of only a few correlated layers, and loops interconnecting neighbouring membranes were 
introduced into the model to represent fusion and allow folding to fit bilayers and plasmid into 
small lamellar domains. Interactions between these domains (Figure 3D) could lead to the 
appearance of long-range fractal aggregates (Figure 3E). This picture is also consistent with the 
fluid behaviour of amphiphile mesophases and provides microphase environments where 
peptides and DNA appear to be spatially separated. In the case of bolaamphiphile-based 
complexes, (shown in Figure 3F-I), the large-scale assembly is represented by peptide 
nanosheets forming a sandwich with nucleic acid strands in-between. The pathway also starts 
with DNA chains mediating the condensation of nanosheets into sandwiched assemblies (Figure 
3F). Due to the high-crystalline order of the nanosheets however, the overall planar structure of 
the complex is maintained (Figure 3I; discussed below). Local ordering is characterized by 
DNA chains condensed onto peptide surfaces, forming weakly-ordered galleries with interaxial 
spacing of ~ 3 nm (Figure 3H). 
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Structural analysis of peptide complexation with plasmid DNA 
The second part of our study focused on complexes prepared using peptide amphiphiles 
and the plasmid vector pEGFP-N1. Samples were prepared under the same conditions used in 
the case of small DNA fragments, i.e., complexes were formulated in buffered solutions (100 
mM Trizma, pH = 7.4) and with peptides and DNA mixed at a 1:1 arginine-to-phosphate ratio. 
Figure 4 shows SAXS data from pellets containing peptide and plasmid. It can firstly be seen 
that scattering from plasmid complexes was remarkably similar to profiles found in conjugates 
prepared with DNA fragments, indicating that the local structure did not depend on the size of 
the nucleic acid sequence. In fact, although the contour length of pEGFP-N1 is much greater 
than that of the fragments used in model complexes (Lplas ~ 4,700  0.34 = 1,600 nm; Lrods ~ 150 
 0.34 = 50 nm), one observed that SAXS from plasmid solutions was quite similar to data 
obtained from solutions with DNA rods (see SI file, Figure S2). The core radius for plasmids 
was fitted at R = 1.1 nm and shell thickness at R = 0.47 nm, slightly bigger than values found 
for sonicated DNA fragments. The length (L) of the cylinders was found to be 145 nm (see SI 
file for all parameters). This arose because structural differences in this case were likely to 
appear at larger scales and the contribution from longer DNA chains was beyond the detection 
range of the technique. Therefore, in the range probed in our SAXS assays, structural features of 
both plasmid- and DNA fragments-based complexes were essentially the same and only slight 
differences were observed between formulations. In the case of PRW-C16/pEGFP-N1 conjugates 
(Figure 4A) the first-order Bragg peak associated with the mean separation between domains 
appeared at q0 = 1.14 nm
-1
, leading to a direct-space distance (d) of 5.5 nm. There was also a 
diffuse peak at q ~ 2.3 nm
-1
 which could either represent a second order Bragg peak and/or it 
could have arisen from the preferred separation of DNA within the peptide nanostructure. The 
correlation length related to inter-domain spacing is  = 30.2 nm, marginally higher than the 
value found for the homologous system with DNA. In the case of RFL4FR/pEGFP-N1 
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complexes (Figure 4B) the periodicity arising from the juxtaposition of one DNA strand plus 
one cross-section bolaamphiphile monolayer remained the same (d = 4.9 nm) and the inter-axial 
separation between DNA strands in the plane of the nanosheets decreased slightly to dDNA = 2.9 
nm. In contrast, the correlation length associated with the repeat distance of the structure 
exhibited a significant increase, from  9.1 nm to  24.0 nm, corresponding to about 5 
correlated layers in the complexes prepared with plasmid and bolaamphiphiles. This finding 
could be related to the contour length of plasmid DNA, which being substantially greater than 
those found in DNA fragments may have contributed to improving inter-sheet interactions.  The 
low-angle region, carrying information from large-scale structures, exhibited a shift of the 
scaling exponent to ~ q
- 2.7 
which is known to be a feature of mass fractals with branched 
networks.
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Cryo-TEM imaging was used to provide direct-space visualization of the topology of 
the complexes (see Figures 4C and D). Formulations prepared using lipopeptides and plasmids 
(Figure 4C) were seen to be characterized by agglomerates of a few hundred of nanometres in 
size, some of which appeared bound together by small threads. Inspecting aggregates in more 
detail, one observes highly-compact assemblies with mosaic patterns looking like 
interpenetrating sheets with internal structures which could be tentatively ascribed to plasmid-
containing lamellae. Fourier transforms carried out over selected portions of the surface (see 
inset in Figure 4C) identified the presence of periodic arrays with repeat distances of ~ 6 nm, in 
good agreement with the separation observed between layers revealed by scattering 
experiments. Although it was not possible to identify DNA strands within the assemblies, 
threads escaping from the complexes had cross-sectional dimensions compatible with the 
diameter expected for DNA chains, implying that polynucleotides were likely to be hosted in 
the interstices of the layered structure. High-magnification imaging (Figure 4E) revealed small 
lamellar domains with alternating bright and dark layers. The separation between layers was 
consistent with the periodicity found in SAXS experiments and the appearance of 
interconnected galleries was clearly visible, in close agreement with the schematic 
representation shown in Figure 3C. In contrast, the complex formulated with the bolaamphiphile 
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(Figure 4D) exhibited the coexistence of tape-like assemblies and fibrils forming a branched 
network and being consistent with large-scale features revealed by SAXS. The images do not 
allow for cross-sectional visualization of sandwiched arrays. However the typical thicknesses of 
tape structures ranging from ~ 8 nm to ~ 25 nm were enough to accommodate several galleries 
of DNA strands absorbed onto the plane of the tapes. Magnified images showing the assemblies 
in more detail, Figure 4F, revealed the presence of plasmid segments lying on the peptide 
surface. Moreover, the average diameter of threads observed across the sample was found to be 
~ 5 nm, which is much thicker than the size expected for a duplex diameter. We propose that 
bolaamphiphile octamers may be condensed in the surroundings of plasmid strands. In addition, 
the appearance of these presumed peptide/plasmid threads bound to tape-like assemblies 
suggested a fusion process leading to flat tape-like assemblies. 
X-ray diffraction was carried out to provide sub-nanometre details on the organization 
of PA/pEGFP-N1 complexes. In Figure 5, two-dimensional diffractograms resulting from these 
experiments exhibited characteristic patterns comprised of concentric Bragg rings. Diffraction 
data from single-component samples (Figures 5A-C) and plots of radially averaged intensities 
as a function of 2Figures 5F and G), are also displayed for comparison. It should be noted 
that the method used for sample preparation led to non-oriented fibres, this being the reason for 
the powder-like DNA patterns obtained by us (Figure 5A), and these do not resemble the 
classical X-shaped behaviour found in highly-oriented fibres.
47, 48
 Peak positions in the DNA 
diffractograms were closely indexed by an orthorhombic unit cell with lattice parameters a = 
3.12 nm, b = 2.27 nm and c = 3.37 nm, which has been widely ascribed to the B-form of the 
double helix
49-51
 (see inset with the simulated pattern in Figure 5A). Data from peptides showed 
different levels of order depending on the nature of the amphiphile used in the formulation. 
Diffraction from the PRW-C16 lipopeptide (Figure 5B) was characterized by three diffuse rings, 
indicating periodic structures with low correlation lengths. A strong reflection at 2= 2.31°, 
associated with repeats of d = 3.82 nm, was ascribed to diameters of dehydrated self-assemblies 
(fibrils), whereas a weak band centred at 2= 6.87° (d = 1.3 nm) likely arose from sheet 
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spacing between tripeptide polar heads, in agreement with FTIR data (see SI file, Figure S3). A 
diffuse outer ring appeared at 2 = 19.89° (d = 0.45 nm), being attributable to separation 
between alkyl chains.
29
 These reflections were straightforwardly indexed to a simple 
orthorhombic cell with parameters a = 3.82 nm, b = 1.3 nm and c = 0.45 nm (see inset). The 
XRD pattern from RFL4FR bolaamphiphiles showed reflections that were much sharper, 
indicating a higher crystalline order in these samples. The array was organized into a cross- 
structure indexed to an orthorhombic unit cell with lattice parameters a = 3.29 nm, b = 1.14 nm 
and c = 0.96 nm, as previously published.
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In contrast to SAXS data, which could not be properly described by combinations of 
contributions from the individual components, the XRD reflections from complexes were more 
straightforward and were interpreted by superposing the repeat distances appearing in the DNA 
or peptide diffractograms. In Figure 5D, the wide-angle region of plasmid/PRW-C16 patterns 
was dominated by the diffuse ring ascribed to separation between alkyl chains in the lipopeptide 
structure. On the other hand, a feature of the low-angle region was Bragg peaks arising from 
separations between phosphate groups in the DNA strands.
49
 Conversely, in the case of 
complexes prepared with the bolaamphiphile, diffraction peaks (Figure 5E) from DNA packing 
were more pronounced in the wide-angle region, whereas those related to peptide organization 
appeared either at small or at wide angles. 
These findings likely indicate that complexation does not affect the structural integrity 
of the pEGFP-N1 cargo which is a key requisite for any such genetic material retaining its 
functional capability. The absence of crystalline features in the diffraction patterns of the 
mixtures of peptides and polynucleotides is suggestive of weaker interactions between these 
species. The molecular organization of such PA/NA conjugates is a key issue for delivery to the 
cellular nucleus where DNA dissociation from such complexes is critical for subsequent gene 
expression. Another important issue in intracellular uptake is the endosomal escape of the 
vehicle after delivery to the cytoplasm of the cell – i.e., after releasing its cargo, the vehicle 
should be metabolized by cellular machinery without further interference or toxicity to the 
cell.
20
 Here, the higher fluidity observed in conjugates formed with the lipopeptide is a potential 
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advantage because such weakly bound structures are presumably easier to unpack either for 
delivery of the load or for endosomal escape of the transfected DNA. 
 
 Peptide-plasmid complexes as tools for in vitro transfection of cells in culture 
The potential of PRW-C16 and RFL4FR peptides to interact with plasmid DNA was also 
investigated using a gel retardation assay in which the appearance of plasmid bands of reduced 
electrophoretic mobility is evidence of peptide-DNA interactions. Increasing dose-dependent 
binding of RFL4FR and PRW-C16 to plasmid DNA was clearly in evidence (see SI file, Figure 
S4), observations that fully concur with those reached during the structural studies described 
above. PRW-C16 and RFL4FR showed greater DNA interactions when peptide quantities were 
higher than ~ 300 ng and ~ 200 ng, respectively, after which the free DNA bands were almost 
completely shifted. Given that the quantity of vector DNA was fixed at 100 ng, one can estimate 
full complexation occurring when the number of arginine residues exceeds that of phosphate 
groups (arginine-to-phosphate ratios above ~ 1.5 and ~ 1.3, for PRW-C16 and RFL4FR). These 
findings reinforce the role of electrostatic interactions as a driving force for complexation and 
suggest that DNA strands act as a mediator of peptide condensation prior to fusion and leading 
to the formation of envelopes surrounding the nucleic acids. The ability to bind cargo through 
electrostatic interactions is beneficial for potential cell-penetrating peptides as there is no need 
for covalent linkage procedures which have the potential to alter the function or efficacy of the 
attached cargo. Conjugation of peptides to cargo may also be costly and laborious, an example 
being the generation of a conjugate of the amphipathic transporter and siRNA, a procedure that 
required synthesis of 5’ thiol groups and disulphide bond formation.52 
 A key aspect of any reagents to be used in transfection studies is their potential for 
cytotoxicity. We chose to investigate this possibility using a dual cell viability assay which 
consisted of a mitochondrial activity assay (Alamar Blue) and a cell membrane integrity assay 
(CFDA-AM). It can be seen that neither peptide showed any significant negative effect on 
SW480 cells, a well-studied colon carcinoma-derived cell line (Figures 5A and 5B), across the 
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concentration ranges used  [up to 5 g/mL (PRW-C16) and 4.5 g/mL (RFL4FR)]. Importantly, 
these upper peptide concentrations were considerably in excess of those used during in vitro 
transfections (3 g/mL PRW-C16 and 2.5 g/mL of RFL4FR, respectively; see below) where 
prior complete complexation of plasmid DNA was first established (see SI file, Figure S4). 
Similar results were also obtained with peptide-plasmid complexes and when the 293 Human 
Embryonic Kidney cell line (HEK 293) was used for transfections (data not shown). The low 
cytotoxic effects of the free peptides and peptide complexes therefore provide an advantage  in 
potential transfection applications in comparison to some other transfection methods such as 
electroporation.  
We next looked for evidence of any potentiating effect of these peptides on the cellular 
uptake of pEGFP-N1. This has been made by assessing EGFP fluorescence from DAPI-stained 
nuclei. In despite accurate determinations are not achieved through fluorescent microscopy, 
estimations on transfection efficiency percentages could be obtained by determining the 
proportion of nuclei emitting the characteristic EGFP fluorescence. Prior complexation of 
plasmid with either peptide led to the appearance of EGFP-expressing cells following 
transfection of SW480 cells, in contrast to when no peptide was used (see Figure 6C). Using 
PRW-C16 as complexation peptide is clearly seen to give a much greater transfection efficiency 
(TE) than is the case with RFL4FR [average TE = 2 ± 1% and 31 ± 5%, respectively), relative to 
the commercial reagent Lipofectamine 2000 (76 ± 6%). Previous studies have suggested a 
correlation between DNA complexation ability and transfection efficiency whereby the 
formation of compact nanoparticle complexes is believed to facilitate membrane translocation 
and transfection.
53
 In the present study, a lower TE as reflected in fewer EGFP-expressing cells, 
does not necessarily indicate the inability of the RFL4FR/DNA complex to penetrate the plasma 
membrane. It is possible that strong electrostatic interactions between RFL4FR and DNA may 
prevent sufficient complex disassembly inside the cell therefore either hindering the delivery of 
DNA cargo to the nucleus or preventing expression of the reporter gene. It is also possible that 
the complexes may become entrapped in an endosome if internalised through endocytic 
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pathways, posing as an obstacle to the usefulness of many CPPs.
54
 The transfection capacity of 
PRW-C16 may be due to its combination of R and W residues and an ability to form micelles 
through lipophilicity. Arginine has been shown to provide electrostatic interactions and 
hydrogen bonding with anionic groups on the cell surface thus promoting uptake. Studies have 
suggested that the resulting peptide charge influenced by R residues can facilitate HSPG 
(Heparan sulphate proteoglycan) binding and also mediate entry through endocytic pathways.
55
 
Interactions from a single R residue may not be sufficient to promote cellular uptake alone, 
however in combination with other residues, may enhance uptake. Elsewhere, tryptophan has 
been linked to DNA intercalation
56
 and membrane destabilisation.
20
 Lipophilic groups, such as 
the hexadecyl chain, have also been shown to play a significant role in cellular uptake. Prata et 
al. demonstrated the influence of the lipophilicity of a similar tripeptide on transfection ability, 
with the sequence KWK (K: lysine; W: tryptophan) indicating a lack of cellular uptake in the 
absence of a C14 chain.
56
 In the present study, the successful delivery of functional plasmid to 
the nucleus suggested that the interdigitated assembly formed was able to maintain stability and 
prevent early inappropriate disassembly. We also noted that transfection efficiencies with PRW-
C16/pEGFP-N1 complexes were comparable in the presence and absence of serum (data not 
shown). This suggests that the scaffolds protect the DNA load from potential nucleases in serum 
and are themselves resistant to proteases and other serum constituents that may destabilise or 
degrade the PA/DNA complexes. This provides a significant advantage as a transfection agent 
as most non-viral methods show reduced transduction efficiencies in the presence of serum. In 
addition to nucleic acids, the structure of the PRW-C16 assemblies formed might also support 
the delivery of hydrophobic molecules through entrapment within the hydrophobic centre of the 
bilayers during their formation. 
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Conclusions 
We presented a comprehensive description of the self-assembly of complexes formed 
between DNA and arginine-containing peptide amphiphiles. For the first time, self-assembly of 
two major types of PAs, a lipopeptide and a bolaamphiphilic peptide, was compared under the 
very same conditions and both were found to easily form complexes with nucleic acids. The 
combination of high-resolution SAXS and contrast-variation SANS provided unprecedented 
insights into the structure and enabled us to accurately determine spatial ordering in both 
complexes.  
On a scale of a few hundred nanometres, complexes based on the lipopeptide PRW-C16 
self-assembled into clustered arrays with large-scale structure exhibiting clear features of 
surface fractal aggregates and DNA strands remaining hosted in the interstice of the peptide 
phase. Interdigitated peptide bilayers, likely intercalating DNA galleries, appeared separated by 
repeat distances of d ~ 5.5 nm, indicating strong condensation of DNA which could enable 
penetration across eukaryotic membranes. In the case of complexes intended for gene delivery, 
organization into condensed nanoclusters is a potentially attractive characteristic because 
clustering in biomolecular arrangements usually implies weak long-range attractive 
interactions.
57
 In fact, unlike bolaamphiphile conjugates whose diffraction patterns exhibit sharp 
Bragg peaks arising from well-ordered structures, wide-angle XRD from lipopeptide complexes 
appeared to be smoother and dominated by diffuse reflections (see Figure 5F). This behaviour 
indicates an absence of long-range order at sub-nanometre level and is also evidence of weak 
non-covalent forces at play for stabilizing assemblies.
58
 During load release, these weakly 
bound structures may represent an advantage that makes for easier disassembly followed by 
delivery of DNA into nucleus. This is supported by transfection efficiencies estimated through 
fluorescence microscopy assays, which indicated that the lipopeptide-based conjugate 
investigated here is much more efficient for enhancing uptake of DNA in comparison to the 
bolaamphiphile complex.  
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In bolaamphiphile-based complexes, stronger forces are presumably involved in long-
range ordering and make unpacking energetically costly. We therefore propose that the 
crystalline nature of bolaamphiphile nanosheets hinders disassembly steps required for load 
release and that this is the basis for the poorer delivery capabilities observed in these complexes. 
In addition, these structures are stiffer and bending peptide nanosheets for wrapping nucleotide 
strands is a process that requires very high energy expenditure. In this case, DNA helices are 
probably not completely “protected” within a peptide envelope formed by bolaamphiphile 
sheets and could be damaged in the extracellular medium. This hypothesis is supported by cryo-
TEM images (see Figures 4D and 4F) that show nucleotide strands partially exposed in 
bolaamphiphile complexes. 
Importantly, cell viability assays showed that both peptides and peptide complexes were 
of limited toxicity to two well-studied cell lines.  Furthermore, and consistent with the structural 
features identified above, our preliminary transfection assays showed that PRW-C16 in particular 
had potential in terms of its ability to assist with gene delivery to cells in culture. Further studies 
will involve optimising the transfection protocol coupled with the use of an expanded range of 
transformed and cultured primary cells, analysing the mechanisms of cellular uptake and 
complex disassembly post-transfection, and investigating the capacity of PRW-C16 to deliver 
cargo including siRNA and molecules other than nucleic acids. In the future, we plan to 
investigate peptide-DNA interactions/transfection efficiencies involving alternative nucleic acid 
cargos such as oligonucleotides and small RNA molecules. Also, the role of different side-
chains in both spatial organization and delivery capabilities will be studied by designing new 
peptide scaffolds in which systematic amino acid substitutions have been introduced into the 
primary sequences investigated in this work. 
 
Supporting Information 
SAXS modelling, fitting parameters, scattering curves, FTIR data and gel retardation 
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Figure 1: Chemical structures of peptide amphiphiles used in this work. Arginine side-chains 
appear coloured in red (colour online). 
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Figure 2: (A) and (B) SAXS curves from PA/DNA complexes together with data from their 
respective single-phase components. Conjugates were prepared with DNA fragments, at 1:1 
arginine-to-phosphate ratio and final peptide concentration of ~ 5 mg/mL. Black arrows point 
to Bragg peaks arising from periodic structures appearing upon complexation and red solid 
lines (colour online) in single-phase plots correspond to model fittings described in the text. 
Scaling exponents of -3.6 and -2 at low-q indicate that assemblies at large-scale are 
characterized, respectively, by surface fractal aggregates and planar geometries. (C) and (D) 
SANS profiles from PA/DNA complexes. Different solvent contrasts were obtained by 
varying D2O content in the medium to separately match scattering length densities of peptides 
and nucleic acids. Black arrows highlight Bragg peaks associated to periodicities in 
conjugates. Differences of q-range are due to different instruments used for data collection 
(see text for details). 
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Figure 3: (Colour online). Schematic drawings of proposed self-assembly pathways and 
tentative structures arising from scattering data. (A)-(E) The lipopeptide-based complex self-
assembles through DNA-mediated condensation of PRW-C16 micelles into interdigitated 
bilayers leading to the formation of local lamellar domains. The large-scale structure is built-
up from inter-domain interactions leading to fractal aggregates. (F)-(I) In bolamphiphile 
complexes, DNA strands mediate condensation of peptide nanosheets leading to the formation 
of sandwiched assemblies with overall planar geometry. 
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Figure 4: (A) and (B) SAXS data from complexes formed between peptide amphiphiles and 
the plasmid vector pEGFP-N1. The structure on the scale probed by SAXS remains essentially 
the same as conjugates made with DNA fragments (compare with Figure 2). (C) and (D) cryo-
TEM micrographs showing large-scale features of DNA complexes with PRW-C16 and 
RFL4FR. On the micrograph from the PRW-C16/pEGFP-N1 (C) the inset shows a Fourier 
transform from the region marked by a white dotted square. (E) and (F) Magnified images 
revealing detailed structure. For the PRW-C16 complex one observes a short lamellar domain 
alternating peptide (white arrows) and DNA regions (black arrows). In the bolaamphiphile 
complex, one sees a peptide tape-like structure (delimited by white lines) with plasmid 
segments absorbed onto the surface (black arrows). 
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Figure 5: (Colour online). Fibre diffraction patterns from DNA, peptides and complexes. 
Insets show theoretical patterns simulated according to orthorhombic unit cells (see text for 
lattice parameters). Diffraction patterns from complexes can be described by the superposition 
of the individual components. 
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Figure 6: (Colour online). (A) and (B) RFL4FR and PRW-C16 demonstrate minimal 
cytotoxicity against SW480 cells. SW480 colon carcinoma cells were incubated with peptides 
and assessed for viability 48 h later using the dual Alamar blue/CFDA-AM assay. The names 
and working concentrations of each peptide used (in g/mL) is given underneath each bar 
chart. Average values of triplicates were calculated following background correction and cited 
as “viability (%)” following reference to vehicle-only treated controls. All data is presented as 
means ± standard deviations (±SD). (C) Prior complexation of pEGFP-N1 with PRW-C16 and 
RFL4FR leads to enhanced uptake of the plasmid by SW480 cells. The figure shows 
representative fluorescent microscopic images of SW480 colon carcinoma cells following 
transfection with pEGFP-N1. Panels on the left-hand side show DAPI-stained cells; the 
corresponding panels on the right hand side show representative results obtained with pEGFP-
N1 alone (-Control), pEGFP-N1/peptide complexes (peptide names are on the right hand side, 
and pEGFP-N1/Lipofectamine complexes (+Control). Transfected cells appear green 
following transfection and expression of EGFP. 
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